An innovative tool which could revolutionise the detection and treatment of musculoskeletal and neurological conditions will be further developed following a $230,000 gift. The donation was made following a campaign by the University of Sydney’s Advancement team and the NORTH Foundation to support the world’s first open-source dataset of whole-body muscle composition. The Kolling Institute’s Academ.....
Read more

If you're looking for the best advice for osteoarthritis care, have a listen to one of our leading clinicians and Kolling Institute researchers Professor David Hunter as he highlights the most effective treatment approaches and the low-value ones to avoid. Thank you to Dr Norman Swan and the team at the ABC's Health Report for the chance to discuss the condition and an exciting clinical trial .....
Read more

The burble of high-powered motorcycles was heard across the Kolling Institute forecourt as part of a 2000 kilometre ride from Melbourne to Armidale to raise awareness and funds for life-changing research. The ride is an initiative of Robert Hunt from the Ulysses Club which has been supporting rheumatoid arthritis research for nearly three decades. The late Stephen Dearnley established the club in 1.....
Read more

A federal government funding boost will pave the way for a much-needed, tailored program for culturally diverse communities experiencing musculoskeletal pain. Dr Saurab Sharma, the Chief Clinical Scientist from the Pain Management and Research Centre at Royal North Shore Hospital, has received a National Health and Medical Research Council investigator grant to progress his research and develop an .....
Read more

For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has long advocated for ‘age-friendly’ clinical .....
Read more

As a clinical trials program lead at the Kolling Institute, Dr Karen Bracken has long been driven to help researchers conduct trials in the best way possible. “Researchers are passionate about their disease area and their patients, and they have so many unanswered questions,” she says. Karen comes from a family of clinicians, and while she didn’t want to practise medicine, she was still drawn to wo.....
Read more

An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports.....
Read more

The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas. “We do trials as it keeps you cutting edge and they are really important for our patients,” she says. As a geriatrician on the frontline, Sue is well posi.....
Read more

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

Kolling Institute researcher and Royal North Shore Hospital endocrinologist Professor Rory Clifton-Bligh has been involved in clinical trials for more than 20 years, focusing on conditions such as osteoporosis, thyroid cancer and diabetes. Patients in the endocrinology clinic have sometimes accessed medication 10 years ahead of other Australians. Many of these drugs have gone on to be listed on the.....
Read more